102 related articles for article (PubMed ID: 38735913)
1. ATP6V1B1 regulates ovarian cancer progression and cisplatin sensitivity through the mTOR/autophagy pathway.
Mo S; Liu T; Zhou H; Huang J; Zhao L; Lu F; Kuang Y
Mol Cell Biochem; 2024 May; ():. PubMed ID: 38735913
[TBL] [Abstract][Full Text] [Related]
2. High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer.
Han GH; Yun H; Chung JY; Kim JH; Cho H
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36999629
[TBL] [Abstract][Full Text] [Related]
3. TTK inhibition increases cisplatin sensitivity in high-grade serous ovarian carcinoma through the mTOR/autophagy pathway.
Qi G; Ma H; Li Y; Peng J; Chen J; Kong B
Cell Death Dis; 2021 Dec; 12(12):1135. PubMed ID: 34876569
[TBL] [Abstract][Full Text] [Related]
4. Damnacanthal isolated from morinda species inhibited ovarian cancer cell proliferation and migration through activating autophagy.
Li R; Li H; Lan J; Yang D; Lin X; Xu H; Han B; Yang M; Su B; Liu F; Jiang W
Phytomedicine; 2022 Jun; 100():154084. PubMed ID: 35421676
[TBL] [Abstract][Full Text] [Related]
5. Activation of PI3K/AKT/mTOR signaling axis by UBE2S inhibits autophagy leading to cisplatin resistance in ovarian cancer.
Zhang M; Wang J; Guo Y; Yue H; Zhang L
J Ovarian Res; 2023 Dec; 16(1):240. PubMed ID: 38115063
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
[TBL] [Abstract][Full Text] [Related]
7. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT
Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137
[TBL] [Abstract][Full Text] [Related]
8. Low concentration of chloroquine enhanced efficacy of cisplatin in the treatment of human ovarian cancer dependent on autophagy.
Zhu J; Zheng Y; Zhang H; Zhu J; Sun H
Am J Transl Res; 2017; 9(9):4046-4058. PubMed ID: 28979680
[TBL] [Abstract][Full Text] [Related]
9. LDLR promotes autophagy-mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway.
Liu L; Sun YH; An R; Cheng RJ; Li N; Zheng JH
Kaohsiung J Med Sci; 2023 Aug; 39(8):779-788. PubMed ID: 37218642
[TBL] [Abstract][Full Text] [Related]
10. Targeting V-ATPase Isoform Restores Cisplatin Activity in Resistant Ovarian Cancer: Inhibition of Autophagy, Endosome Function, and ERK/MEK Pathway.
Kulshrestha A; Katara GK; Ibrahim SA; Riehl V; Sahoo M; Dolan J; Meinke KW; Pins MR; Beaman KD
J Oncol; 2019; 2019():2343876. PubMed ID: 31057611
[TBL] [Abstract][Full Text] [Related]
11. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
12. Label-free-based quantitative proteomic analysis of the inhibition of cisplatin-resistant ovarian cancer cell proliferation by cucurbitacin B.
Yin S; Mai Z; Liu C; Xu L; Xia C
Phytomedicine; 2023 Mar; 111():154669. PubMed ID: 36681055
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.
He J; Yu JJ; Xu Q; Wang L; Zheng JZ; Liu LZ; Jiang BH
Autophagy; 2015; 11(2):373-84. PubMed ID: 25650716
[TBL] [Abstract][Full Text] [Related]
14. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
Zhu H; Diao S; Lim V; Hu L; Hu J
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
[TBL] [Abstract][Full Text] [Related]
15. Dihydroartemisinin potentiates the anticancer effect of cisplatin via mTOR inhibition in cisplatin-resistant ovarian cancer cells: involvement of apoptosis and autophagy.
Feng X; Li L; Jiang H; Jiang K; Jin Y; Zheng J
Biochem Biophys Res Commun; 2014 Feb; 444(3):376-81. PubMed ID: 24462866
[TBL] [Abstract][Full Text] [Related]
16. FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer.
Zhu W; Huang M; Thakur A; Yan Y; Wu X
PeerJ; 2023; 11():e14827. PubMed ID: 36751636
[TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_0000585 promotes chemoresistance to cis-platin in epithelial cells of ovarian cancer by modulating autophagy.
Du P; Xu X; Wang Y
Biochem Biophys Res Commun; 2023 Oct; 678():186-192. PubMed ID: 37643536
[TBL] [Abstract][Full Text] [Related]
18. TRP14 promotes resistance to cisplatin by inducing autophagy in ovarian cancer.
Tan WX; Xu TM; Zhou ZL; Lv XJ; Liu J; Zhang WJ; Cui MH
Oncol Rep; 2019 Oct; 42(4):1343-1354. PubMed ID: 31524236
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA growth arrest-specific 5 facilitates glioma cell sensitivity to cisplatin by suppressing excessive autophagy in an mTOR-dependent manner.
Huo JF; Chen XB
J Cell Biochem; 2019 Apr; 120(4):6127-6136. PubMed ID: 30317677
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and characterization of Atp6v1b1, the murine vacuolar H+ -ATPase B1-subunit.
Finberg KE; Wagner CA; Stehberger PA; Geibel JP; Lifton RP
Gene; 2003 Oct; 318():25-34. PubMed ID: 14585495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
